Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Non-Current Assets: 2020-2025

Historic Non-Current Assets for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Sep 2025 value amounting to $21.8 million.

  • Arcutis Biotherapeutics' Non-Current Assets rose 59.55% to $21.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.8 million, marking a year-over-year increase of 59.55%. This contributed to the annual value of $13.1 million for FY2024, which is 19.53% up from last year.
  • Arcutis Biotherapeutics' Non-Current Assets amounted to $21.8 million in Q3 2025, which was up 10.67% from $19.7 million recorded in Q2 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' Non-Current Assets peaked at $21.8 million during Q3 2025, and registered a low of $5.0 million during Q2 2022.
  • Over the past 3 years, Arcutis Biotherapeutics' median Non-Current Assets value was $11.8 million (recorded in 2023), while the average stood at $14.1 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 958.56% in 2021, then decreased by 13.98% in 2024.
  • Arcutis Biotherapeutics' Non-Current Assets (Quarterly) stood at $5.4 million in 2021, then spiked by 120.64% to $11.9 million in 2022, then dropped by 7.87% to $10.9 million in 2023, then rose by 19.53% to $13.1 million in 2024, then skyrocketed by 59.55% to $21.8 million in 2025.
  • Its Non-Current Assets was $21.8 million in Q3 2025, compared to $19.7 million in Q2 2025 and $20.4 million in Q1 2025.